Caliber Imaging & Diagnostics Inc
OTC:LCDX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0001
0.02
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Caliber Imaging & Diagnostics Inc
Cash from Operating Activities
Caliber Imaging & Diagnostics Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Caliber Imaging & Diagnostics Inc
OTC:LCDX
|
Cash from Operating Activities
-$4.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
7%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$4.6B
|
CAGR 3-Years
57%
|
CAGR 5-Years
25%
|
CAGR 10-Years
21%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$4.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$9.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
Caliber Imaging & Diagnostics Inc
Glance View
Caliber Imaging & Diagnostics, Inc. operates as a medical technologies company that designs, develops, and markets imaging solutions that shows tissue at the cellular level. The company is headquartered in Andover, Massachusetts and currently employs 28 full-time employees. The company went IPO on 2012-02-27. The firm is engaged in manufacturing of in-vivo reflectance confocal microscope and ex-vivo confocal imaging equipment for the medical device, clinical research and life science industries. The Company’s products include clinical and research. Its clinical products include VivaScope 1500, VivaScope 2500, VivaScope 3000, VivaNet and VivaScan. The Company’s research products include RS-G4 Upright, RS-G4 Inverted, Specialty Confocal Microscopes and Research Software Suite. The VivaScope 1500 is reflectance confocal imaging system used to capture confocal images that depict cellular structures of living tissue, without the need for lengthy preparation protocols. The VivaScope 2500 is a confocal microscope specially designed for imaging fresh, needle aspirated, or fixed specimens in reflectance (phase contrast) mode or in fluorescence mode for specimens stained with fluorochromes.
See Also
What is Caliber Imaging & Diagnostics Inc's Cash from Operating Activities?
Cash from Operating Activities
-4.8m
USD
Based on the financial report for Dec 31, 2013, Caliber Imaging & Diagnostics Inc's Cash from Operating Activities amounts to -4.8m USD.
What is Caliber Imaging & Diagnostics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-6%
Over the last year, the Cash from Operating Activities growth was 37%. The average annual Cash from Operating Activities growth rates for Caliber Imaging & Diagnostics Inc have been -6% over the past three years .